Novel approaches to pediatric vaccine delivery

被引:28
作者
O'Hagan, DT
Rappuoli, R
机构
[1] Chiron Vaccines, Oakland, CA 94608 USA
[2] Chiron Vaccines, I-53100 Siena, Italy
关键词
vaccine delivery; vaccine adjuvants; needle-free immunization; topical immunization;
D O I
10.1016/j.addr.2005.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although currently available vaccines represent an outstanding success story in modem medicine and have had a dramatic effect on morbidity and mortality worldwide, it is clear that improvements in vaccine delivery are required. Vaccine delivery improvements may include the addition of novel injectable adjuvants, or the use of novel routes of delivery, including mucosal immunization. Mucosal delivery may be required to provide protection against pathogens that infect at mucosal sites, including sexually transmitted diseases. Alternatively, novel approaches to delivery, including mucosal administration, may be used to improve compliance for existing vaccines. Of particular interest for safer mass immunization are needle-free delivery devices, which would avoid problems due to needle re-use in many parts of the world, or needle-stick injuries. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 51
页数:23
相关论文
共 163 条
  • [11] Serum antibody responses after intradermal vaccination against influenza
    Belshe, RB
    Newman, FK
    Cannon, J
    Duane, C
    Treanor, J
    Van Hoecke, C
    Howe, BJ
    Dubin, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (22) : 2286 - 2294
  • [12] Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643
  • [13] Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity
    Bendelac, A
    Medzhitov, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : F19 - F23
  • [14] Oral vaccination in man using antigens in particles: current status
    Brayden, DJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (03) : 183 - 189
  • [15] The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery
    Briones, M
    Singh, M
    Ugozzoli, M
    Kazzaz, J
    Klakamp, S
    Ott, G
    O'Hagan, D
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (05) : 709 - 712
  • [16] AN OUTBREAK OF HEPATITIS-B ASSOCIATED WITH JET INJECTIONS IN A WEIGHT-REDUCTION CLINIC
    CANTER, J
    MACKEY, K
    GOOD, LS
    ROBERTO, RR
    CHIN, J
    BOND, WW
    ALTER, MJ
    HORAN, JM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (09) : 1923 - 1927
  • [17] Epidermal powder immunization of mice and monkeys with an influenza vaccine
    Chen, DX
    Endres, R
    Maa, YF
    Kensil, CR
    Whitaker-Dowling, P
    Trichel, A
    Youngner, JS
    Payne, LG
    [J]. VACCINE, 2003, 21 (21-22) : 2830 - 2836
  • [18] Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
    Chen, DX
    Endres, RL
    Erickson, CA
    Weis, KF
    McGregor, MW
    Kawaoka, Y
    Payne, LG
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1187 - 1190
  • [19] DNA vaccination with the human immunodeficiency virus type 1 SF162ΔV2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8+ T-cell-depleted rhesus macaques
    Cherpelis, S
    Shrivastava, I
    Gettie, A
    Jin, X
    Ho, DD
    Barnett, SW
    Stamatatos, L
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (03) : 1547 - 1550
  • [20] FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP
    CLEMENS, JD
    SACK, DA
    HARRIS, JR
    VANLOON, F
    CHAKRABORTY, J
    AHMED, F
    RAO, MR
    KHAN, MR
    YUNUS, M
    HUDA, N
    STANTON, BF
    KAY, BA
    WALTER, S
    EECKELS, R
    SVENNERHOLM, AM
    HOLMGREN, J
    [J]. LANCET, 1990, 335 (8684) : 270 - 273